Envista Holdings Corporation
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Paul A. Keel
- Full Time Employees
- 12,000
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Building E Brea CA United States 92821-6208
- IPO Date
- Sep 18, 2019
- CIK
- 0001757073
- Website
- envistaco.com
- Similar Companies
- Business
- Envista Holdings Corp (NYSE: NVST) develops and manufactures a broad portfolio of dental products and technologies for dental professionals worldwide. The company operates through two primary segments: Specialty Products & Technologies, which offers dental implant systems, prosthetics, clear aligners, brackets and wires, orthodontic and laboratory products; and Equipment & Consumables, which provides digital imaging systems, dental practice equipment, endodontic systems, restorative and impression materials, bonding agents and cements, and infection prevention products. Envista serves dental offices, orthodontists, oral surgeons, and laboratories with innovative solutions supporting integrated digital workflows, training programs, and comprehensive patient care tools across more than 120 countries. Founded in 2019 as a spin-off from Danaher Corp and headquartered in Brea, California, the company encompasses over 30 trusted brands with more than 125 years of combined industry heritage. In June 2025, Envista acquired Alpha-Bio France to strengthen its implant and prosthetics offerings in Europe; the company continues strategic mergers and acquisitions to expand its global reach and technological capabilities, anchored by the Envista Business System for operational excellence.
Company News
What Envista (NVST) Said on Its Q3 Earnings Call
Envista Holdings Corporation (NVST) Q3 2026 Earnings Call Transcript
Envista (NVST) Reports Q3 Earnings: What Key Metrics Have to Say
Envista (NVST) Tops Q3 Earnings and Revenue Estimates
Envista Reports Third Quarter 2026 Results
Envista Q3 Earnings Ahead: Product Innovation to Drive Growth
Envista (NVST) Earnings Expected to Grow: Should You Buy?
Envista Announces Release of 2025 Sustainability Report
Reviewing MariMed (OTCMKTS:MRMD) and Envista (NYSE:NVST)
Envista Holdings Corporation (NYSE:NVST) Stock Rated “Hold” by Wall Street Brokerages
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
Here's Why Envista (NVST) is a Strong Growth Stock
Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?
Envista Schedules Third Quarter 2026 Earnings Call
New Strong Buy Stocks for September 28th
NVST vs. ABT: Which Stock Is the Better Value Option?
Best Value Stocks to Buy for September 21st
Should Value Investors Buy Envista (NVST) Stock?
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript